August 28, 2016 8:30 AM ET


Company Overview of InCarda Therapeutics, Inc.

Company Overview

InCarda Therapeutics, Inc. develops transformative therapies that enable patients to use in the first moments of acute cardiovascular symptoms. The company develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. InCarda Therapeutics, Inc. was formerly known as Pleiades Cardio-Therapeutics, Inc. The company was incorporated in 2009 and is based in San Francisco, California.

150 Post Street

Suite 650

San Francisco, CA 94108

United States

Founded in 2009





Key Executives for InCarda Therapeutics, Inc.

Chief Executive Officer and President
Co-Founder and Executive Chairman
Age: 68
Co-Founder and Chief Operating Officer
Co-Founder and Chief Scientific Officer
Co-Founder and Chief Medical Officer for Consulting
Compensation as of Fiscal Year 2016.

InCarda Therapeutics, Inc. Key Developments

InCarda Therapeutics, Inc. Elects Norbert Bischofberger to Board of Directors

InCarda Therapeutics, Inc. announced the election of Norbert Bischofberger to the company's board of directors. Dr. Bischofberger has spent over 25 years at Gilead Sciences, where he currently serves as the company's chief scientific officer and executive vice president of research and development. Dr. Norbert Bischofberger has served at Gilead Sciences since 1990 and is currently the company's chief scientific officer and executive vice president of research and development.

InCarda Therapeutics, Inc. Appoints Luiz Belardinelli as Chief Medical Officer

InCarda Therapeutics, Inc. has appointed Luiz Belardinelli, M.D., to the position of Chief Medical Officer. Dr. Belardinelli joins InCarda for this position half-time and plans to also continue in his role at Gilead Sciences where he serves as a Senior Advisor for the Cardiovascular Therapeutic Area of Gilead. Dr. Belardinelli is currently Senior Advisor for the Cardiovascular Therapeutic Area of Gilead Sciences.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact InCarda Therapeutics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at